---
title: "Allgens' subsidiary obtains medical device production license"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/246791082.md"
description: "Allgens' wholly-owned subsidiary, Beijing Allgens Medical Devices Co., Ltd., recently obtained a medical device manufacturing license issued by the Beijing Municipal Medical Products Administration, with a production scope that includes Class III absorbable surgical dressings. This license provides qualification assurance for the production and market sales of the company's future products and is expected to have a positive impact on the company's operations"
datetime: "2025-07-01T08:19:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/246791082.md)
  - [en](https://longbridge.com/en/news/246791082.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/246791082.md)
---

# Allgens' subsidiary obtains medical device production license

According to the Zhitong Finance APP, Allgens (688613.SH) announced that its wholly-owned subsidiary, Beijing Allgens Medical Devices Co., Ltd., recently received the "Medical Device Manufacturing License" issued by the Beijing Municipal Drug Administration. The production scope includes: Class III: III-14-08 absorbable surgical dressings (materials).

The acquisition of the "Medical Device Manufacturing License" provides qualification assurance for the formal production and market sales of the company's future products. The company will organize production in accordance with relevant regulations, standards, and product technical requirements such as the "Regulations on the Supervision and Administration of Medical Devices" and the "Measures for the Supervision and Administration of Medical Device Production," ensuring product quality and production capacity to meet market demand, which is expected to have a positive impact on the company's future operations

### Related Stocks

- [688613.CN](https://longbridge.com/en/quote/688613.CN.md)

## Related News & Research

- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)
- [BRIEF-Mexico's Fibra Next Extends, Raises Public Offer For Fibra Macquarie](https://longbridge.com/en/news/287128862.md)
- [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md)
- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [05:54 ETTermHub™ Launches New Managed FHIR Offering for SDOs](https://longbridge.com/en/news/287042225.md)